ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,200Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 403

$508K Total Retail Price of All Prescriptions

Rank: 48 out of 403

283 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 283 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 283 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,432 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 315 307 1 2
WARFARIN SODIUM 315 255 1 12
LEVOTHYROXINE SODIUM 235 225 3 3
LISINOPRIL 217 201 4 1
AMLODIPINE BESYLATE 216 191 5 4
FUROSEMIDE 211 194 6 7
METOPROLOL TARTRATE 208 178 7 10
RAMIPRIL 200 175 8 75
ZOLPIDEM TARTRATE 139 123 9 16
ATORVASTATIN CALCIUM 137 121 10 5
METOPROLOL SUCCINATE 133 131 11 11
HYDROCHLOROTHIAZIDE 126 112 12 6
CITALOPRAM HBR 125 125 13 22
CRESTOR 115 98 14 19
OMEPRAZOLE 105 101 15 9
POTASSIUM CHLORIDE 103 86 16 37
TRAZODONE HCL 101 101 17 25
METFORMIN HCL 100 80 18 8
DONEPEZIL HCL 99 99 19 23
RISPERIDONE 85 85 20 48
MIRTAZAPINE 82 82 21 38
ATENOLOL 71 71 22 13
ADVAIR DISKUS 71 64 22 33
NAMENDA 67 63 24 41
LANTUS 66 53 25 54
FENTANYL 64 64 S2 26 71
CYMBALTA 63 25 27 43
LIDODERM 62 62 28 74
FLUTICASONE PROPIONATE 61 61 29 47
SERTRALINE HCL 60 49 30 20
CARVEDILOL 57 57 31 32
OXYCODONE-ACETAMINOPHEN 55 45 S2 32 45
ESCITALOPRAM OXALATE 52 48 33 36
GABAPENTIN 50 26 34 17
SPIRIVA 50 47 34 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.